ArticleBioengineering (Basel, Switzerland)2023

Development of a Molecular-Subtype-Associated Immune Prognostic Signature That Can Be Recognized by MRI Radiomics Features in Bladder Cancer.

Shenghua Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.